Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.42 |
| ▸ | FBP1 | P09467 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SGK1 | O00141 | 1/20 | 0.41 |
| ▸ | ACLY | P53396 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23010357 | 1.00 | KMT2A (0.52) | KMT2ASMN1; SMN2GAAMAPK1MAPT | |
| SCHEMBL23010370 | 0.86 | MCL1 (0.49) | KMT2AMAPK1MAPTALDH1A1MEN1 | |
| SCHEMBL29434875 | 0.86 | MCL1 (0.49) | KMT2AMAPK1MAPTALDH1A1MEN1 | |
| SCHEMBL29434833 | 0.85 | L3MBTL1 (0.43) | KMT2ASMN1; SMN2MAPTALDH1A1MEN1 | |
| SCHEMBL23010358 | 0.85 | L3MBTL1 (0.43) | KMT2ASMN1; SMN2MAPTALDH1A1MEN1 | |
| SCHEMBL22981705 | 0.84 | SLC22A12 (0.44) | KMT2ASMN1; SMN2GAAALDH1A1MEN1 | |
| SCHEMBL29434842 | 0.84 | SLC22A12 (0.44) | KMT2ASMN1; SMN2GAAALDH1A1MEN1 | |
| SCHEMBL22980359 | 0.80 | PTGES2 (0.47) | KMT2ASMN1; SMN2GAAMAPK1MAPT | |
| SCHEMBL29434824 | 0.80 | PTGES2 (0.47) | KMT2ASMN1; SMN2GAAMAPK1MAPT | |
| SCHEMBL22980484 | 0.79 | SMN1; SMN2 (0.49) | KMT2ASMN1; SMN2GAAMAPK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114174266-A | Arylsulfonamide derivatives as MGLUR4 negative allosteric modulators | 豪夫迈·罗氏有限公司 | 2022-03-11 | — | — | CN | claimed |
| US-12065399-B2 | Arylsulfonamide derivatives | HOFFMANN-LA ROCHE INC. (US) | 2024-08-20 | — | — | US | disclosed |
| US-20220169599-A1 | ARYLSULFONAMIDE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2022-06-02 | — | — | US | disclosed |
| CN-114174266-A | Arylsulfonamide derivatives as MGLUR4 negative allosteric modulators | 豪夫迈·罗氏有限公司 | 2022-03-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220169599-A1 | ARYLSULFONAMIDE DERIVATIVES | ARSA, SULT1E1, STS | KMT2A 837/4885SMN1; SMN2 1681/4885GAA 1211/4885 |
| US-12065399-B2 | Arylsulfonamide derivatives | ARSA, SULT1E1, STS | KMT2A 837/4885SMN1; SMN2 1681/4885GAA 1211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.